A Certificate of Analysis (CoA) is a document provided by a peptide manufacturer or testing laboratory that reports the analytical results confirming the identity, purity, and quality of a specific batch of material. For research purposes, the CoA is one of the most important documents accompanying any peptide product – it’s the primary evidence that what’s in the vial matches what’s on the label, and at what quality.
This guide explains how to read and interpret the key sections of a typical peptide CoA.
Why the CoA Matters
Peptide synthesis is a complex chemical process, and even well-controlled manufacturing can produce batch-to-batch variation in purity, related impurities, and exact peptide content. A CoA provides batch-specific, third-party or in-house verified data, rather than relying on generic product specifications alone. For research applications where reproducibility matters, reviewing the CoA for the specific batch you’ve received -not just a generic product page – is good practice.
Key Sections of a Typical CoA
1. Batch/Lot Number
Every CoA should reference a specific batch or lot number, which should match the number printed on your vial’s label. If these don’t match, the CoA you have may not correspond to the material you actually received, and you should contact the supplier for clarification.
2. Peptide Identity Confirmation
This section confirms that the material is, in fact, the peptide it’s labelled as. Common identity-confirmation methods include:
- Mass spectrometry (MS): confirms the molecular weight of the peptide matches the expected theoretical mass. Results are typically reported as an observed mass compared against the calculated/theoretical mass, with a small acceptable margin of difference.
- High-performance liquid chromatography (HPLC) retention time: while HPLC is primarily a purity test (see below), retention time can also support identity confirmation when compared against a reference standard.
3. Purity (HPLC Analysis)
This is usually the most prominently reported figure on a CoA, expressed as a percentage (e.g. “Purity: 98.5%”). HPLC works by separating the components of a sample as they pass through a column, with the main peptide peak and any impurity peaks detected and quantified by area under the curve. The reported purity percentage typically represents the target peptide’s peak area as a proportion of total detected peak area.
Things to check in this section:
- The overall purity percentage
- Whether a chromatogram image is included (allowing visual inspection of peak shape and any secondary peaks)
- The column type and method conditions used, which can affect comparability between different suppliers’ purity claims
4. Mass Spectrometry Data
Beyond identity confirmation, MS data may include more detailed information such as the specific ionisation method used (e.g. ESI-MS, MALDI-TOF) and the observed mass-to-charge ratio. For researchers needing high confidence in compound identity, reviewing the raw MS data (not just a pass/fail statement) provides more substantive information.
5. Peptide Content / Net Peptide Content
This figure is distinct from purity and is sometimes omitted from basic CoAs, though it’s highly relevant for accurate concentration calculations. “Peptide content” or “net peptide content” reflects what proportion of the vial’s total mass is actually the active peptide itself, as opposed to counter-ions, residual solvents, water content, and other non-peptide material that can be present in lyophilized powder. A vial may state “5mg” of total powder weight, but the actual net peptide content could be meaningfully lower – this distinction matters significantly for accurate concentration calculations during reconstitution (see our Peptide Concentration & Volume Calculation Guide).
6. Appearance Description
A brief description of the lyophilized powder’s expected physical appearance (colour, form) for that specific peptide, useful as a basic visual cross-check upon receipt.
7. Storage Recommendations
Many CoAs include manufacturer-recommended storage conditions (temperature, light exposure, lyophilized vs. reconstituted handling), which should generally take precedence over generic storage guidance if the two differ, since they reflect testing specific to that manufacturer’s formulation.
8. Testing Laboratory and Method Information
Reputable CoAs identify whether testing was conducted in-house or by an independent third-party laboratory, along with the specific analytical methods used. Third-party verification generally provides a higher degree of confidence than purely in-house testing, since it removes potential conflicts of interest in reporting.
Red Flags to Watch For
- No batch/lot number, making it impossible to confirm the CoA corresponds to your specific vial
- Missing or vague testing methodology (e.g. no mention of HPLC conditions or MS method)
- No chromatogram or raw data included, only a summary purity percentage with no supporting visual or numerical detail
- Purity figures with no accompanying identity confirmation – a high purity percentage is much less meaningful if the material’s identity hasn’t been independently confirmed
- CoA dated significantly earlier than your purchase, which may indicate the document doesn’t correspond to current stock
- Internally inconsistent data (e.g. stated molecular weight not matching the named peptide’s known theoretical mass)
How to Use CoA Data in Practice
- Always check that the batch number on your CoA matches your vial label before use
- Use the net peptide content figure (not just total vial weight) when calculating reconstitution concentrations, where this data is provided
- Keep CoAs on file alongside your research records for traceability, particularly important if results need to be reproduced or compared across batches later
- If a CoA is missing key sections or seems inconsistent, contact the supplier for clarification before relying on the material for research use
FAQ
What’s the difference between “purity” and “peptide content”? Purity (typically via HPLC) describes what proportion of the peptide material itself is the target compound versus synthesis-related impurities. Peptide content describes what proportion of the total vial weight is actual peptide, versus counter-ions, moisture, and other non-peptide material – a vial can have very high purity but still have peptide content meaningfully below the stated total weight.
Why might two suppliers report different purity figures for the “same” peptide? HPLC conditions (column type, mobile phase, detection wavelength) can affect what’s detected and how peak areas are calculated, so purity figures aren’t always directly comparable between different testing methods or laboratories without knowing the underlying method.
Is third-party testing always better than in-house testing? Third-party testing generally provides stronger independent verification and removes potential reporting conflicts of interest, but well-documented, methodologically transparent in-house testing can still be informative – the key factor is the transparency and rigour of the methodology, not simply who performed it.
What should I do if the CoA doesn’t match the batch number on my vial? Contact the supplier directly for the correct, batch-matched CoA before relying on the material for research purposes – a mismatched CoA provides no real assurance about the specific material you’ve received.
Does a CoA guarantee a peptide is free of contamination? Not necessarily – most standard CoAs focus on identity and purity relative to the synthesis process, and may not include separate microbial or endotoxin testing unless specifically stated. Check whether your CoA includes this information if it’s relevant to your research application.